| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/06/1993 | CA2091024A1 Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds |
| 09/06/1993 | CA2090957A1 Anti-tumor method and anti-tumor agent |
| 09/05/1993 | CA2090834A1 Analysis of host cell shut-offs |
| 09/05/1993 | CA2090295A1 Process for the expression of herpes simplex virus type 1 glycoprotein e and methods of use |
| 09/04/1993 | CA2090639A1 Polypeptides and dnas encoding them |
| 09/02/1993 | WO1993017337A1 Method for modulating proopiomelanocortin synthesis in a mammal |
| 09/02/1993 | WO1993017127A1 Boomerand dna amplification |
| 09/02/1993 | WO1993017123A1 Mutagenicity testing using reporter genes with modified methylation frequencies |
| 09/02/1993 | WO1993017122A1 Protein with novel pharmacological characteristic |
| 09/02/1993 | WO1993017119A2 A 90k tumor-associated antigen, ir-95 |
| 09/02/1993 | WO1993017118A2 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 09/02/1993 | WO1993017117A1 Heterologous gene expression in lactococcus, and the expression products therefrom |
| 09/02/1993 | WO1993017115A2 Dysentery vaccine stimulating an immune response against shigatoxin, plasmids and host strains for it |
| 09/02/1993 | WO1993017113A1 RECOMBINANT β-LACTAMASE USABLE AS CARRIER MOLECULE FOR THE PREPARATION OF IMMUNOGENIC COMPOSITIONS |
| 09/02/1993 | WO1993017111A1 Hepatitis c virus peptides |
| 09/02/1993 | WO1993017110A2 A recombinant hepatitis c virus polypeptide |
| 09/02/1993 | WO1993017109A1 Ibv spike protein (2) |
| 09/02/1993 | WO1993017108A2 Analogous peptides of the internal image of a viral protein |
| 09/02/1993 | WO1993017107A1 Improvements in or relating to malaria vaccine |
| 09/02/1993 | WO1993017106A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 09/02/1993 | WO1993017104A1 Dna sequence of myotonic distrophy gene and uses thereof |
| 09/02/1993 | WO1993017102A1 MODULATIONS OF CELLULAR FUNCTIONS WITH HnRNP PROTEINS |
| 09/02/1993 | WO1993017099A1 Protein for inhibiting collagen-stimulated platelet aggregation |
| 09/02/1993 | WO1993017098A1 Production of viral resistant plants via introduction of untranslatable plus sense viral rna |
| 09/02/1993 | WO1993017095A1 In vitro activation of cytotoxic t cells |
| 09/02/1993 | WO1993017093A2 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |
| 09/02/1993 | WO1993017086A1 A detergent containing a protease and a protease inhibitor and novel inhibitors for use therein |
| 09/02/1993 | WO1993017046A1 Novel lectinlike substance |
| 09/02/1993 | WO1993017045A1 A novel serum growth factor |
| 09/02/1993 | WO1993017043A1 Methods and compounds for prevention of graft rejection |
| 09/02/1993 | WO1993017042A1 Means for testing products containing milk proteins |
| 09/02/1993 | WO1993017041A1 Car receptors and related molecules and methods |
| 09/02/1993 | WO1993017040A2 Cystic fibrosis transmembrane conductance regulator (cftr) protein |
| 09/02/1993 | WO1993017038A1 Methods of treating diabetes |
| 09/02/1993 | WO1993017033A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | WO1993017031A2 Nucleic acids encoding dystrophin-associated proteins |
| 09/02/1993 | WO1993016726A2 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 09/02/1993 | WO1993016725A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | WO1993016724A1 Bystander suppression of autoimmune diseases |
| 09/02/1993 | WO1993016723A1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 09/02/1993 | WO1993016722A1 Antigens protective against echinococcus granulosus infection and vaccines containing such antigens |
| 09/02/1993 | WO1993016719A2 Use of platelet derived growth factor in ophthalmic wound healing |
| 09/02/1993 | WO1993016718A1 Hepatoma treatment with somatostatin analogs |
| 09/02/1993 | WO1993016717A1 Method and agents for promoting wound healing |
| 09/02/1993 | WO1993016716A1 Method and composition for inhibiting angiogenesis |
| 09/02/1993 | WO1993016715A1 Fsf-1 and the early detection of fibrosis |
| 09/02/1993 | WO1993016712A1 MUTANT GPIbα FRAGMENTS AND RECOMBINANT EXPRESSION THEREOF |
| 09/02/1993 | WO1993016709A1 Therapeutic domains of von willebrand factor |
| 09/02/1993 | WO1993015112A3 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
| 09/02/1993 | WO1993013740A3 Antiparasitic oligonucleotides active against drug resistant malaria |
| 09/02/1993 | CA2131028A1 Hepatitis c virus peptides |
| 09/02/1993 | CA2130997A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | CA2130802A1 Methods and compounds for prevention of graft rejection |
| 09/02/1993 | CA2130748A1 Use of platelet derived growth factor in ophthalmic wound healing |
| 09/02/1993 | CA2130453A1 Heterologous gene expression in lactococcus, and the expression products threrefrom |
| 09/02/1993 | CA2130182A1 Methods of treating diabetes |
| 09/02/1993 | CA2130082A1 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |
| 09/02/1993 | CA2129987A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | CA2129982A1 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 09/02/1993 | CA2129827A1 Analogous peptides of a viral protein internal image |
| 09/02/1993 | CA2117607A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 09/02/1993 | CA2117491A1 Car receptors and related molecules and methods |
| 09/02/1993 | CA2117468A1 Ibv spike protein (2) |
| 09/02/1993 | CA2107773A1 Hepatoma treatment with somatostatin analogs |
| 09/01/1993 | EP0557966A1 Prostaglandin E receptors, their DNA and production |
| 09/01/1993 | EP0557897A1 Antigen binding proteins and methods for their production |
| 09/01/1993 | EP0557663A1 Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin |
| 09/01/1993 | EP0557469A1 Plant medium-chain thioesterases |
| 09/01/1993 | EP0557467A1 Diagnostic testing for campylobacter jejuni or coli infection using antigens |
| 09/01/1993 | EP0557455A1 Recombinant feline coronavirus s proteins |
| 09/01/1993 | EP0557442A1 Antithrombosis agents |
| 09/01/1993 | EP0557427A1 Human rotaviruses, vaccines and methods |
| 09/01/1993 | EP0557424A1 Skin-associated lymphocytes and markers |
| 09/01/1993 | EP0557420A1 Method for inducing maturation of myeloid cells with interleukin-5 |
| 09/01/1993 | EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR |
| 09/01/1993 | EP0557417A1 Compositions for reducing oxidative injury |
| 09/01/1993 | EP0557388A1 Diagnosis and treatment of multiple sclerosis |
| 09/01/1993 | EP0557383A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 09/01/1993 | EP0557273A1 Rat thyrotropin receptor gene and uses thereof |
| 09/01/1993 | EP0527954A4 Molecular recognition units |
| 09/01/1993 | EP0434675B1 Polypeptide compounds having growth hormone releasing activity |
| 09/01/1993 | EP0241539B1 Expression systems for overproduction of desired proteins |
| 09/01/1993 | CN1021973C Production of proteins in procaryotes |
| 08/31/1993 | US5241072 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof |
| 08/31/1993 | US5241053 Glycoprotein of Herpes simplex virus type 1 and heat-labile enterotoxin B subunit; enhanced absorption for immunization through nasal mucosa |
| 08/31/1993 | US5241052 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 08/31/1993 | US5241051 Secreted by human erythroblastoid cells |
| 08/31/1993 | US5241050 Treating pancreatic diseases; antitumor agents |
| 08/31/1993 | US5241049 Neutrophil chemoattractants |
| 08/31/1993 | US5241047 Synthetic peptides and mixtures thereof for detecting HIV antibodies |
| 08/31/1993 | US5240913 Inhibitors of thrombin |
| 08/31/1993 | US5240912 Transforming growth factor (TGF) peptides |
| 08/31/1993 | US5240911 Method of reducing blood sugar levels using a hypoglycemic agent |
| 08/31/1993 | US5240864 Method of assaying or analyzing subtypes of human leukocyte interferons or their antibodies, and antibodies to be used therefor |
| 08/31/1993 | US5240848 Cloning; genetic engineering |
| 08/31/1993 | US5240847 Cloned gene |
| 08/31/1993 | US5240846 Gene therapy vector for cystic fibrosis |
| 08/31/1993 | US5240845 Having specified amino acid sequence |
| 08/31/1993 | US5240841 E. coli resistance to Qβ virus infection |
| 08/31/1993 | US5240840 Dna superfragment cloning |